Eric Vallieres MD, FRCSC

Dr. Vallieres is the Medical Director Division of Thoracic Surgery at the Swedish Cancer Institute in Seattle. He received his MD from L’Université Laval in Canada. Following an internship in Québec City, he trained in General Surgery at the University of Toronto where he also completed a General Thoracic Surgery Residency. Following a fellowship with Professeur Couraud in Bordeaux, France, he joined the Department of Surgery at the University of Alberta Edmonton in 1991, then the University of Ottawa in 1994. He was recruited to the Division of Cardiothoracic Surgery at the University of Washington Seattle in 1996 where he remained as an Associate Professor until 2004, before taking over the leadership of Thoracic Surgery at the Swedish Cancer Institute.

Dr. Vallières was Vice-Chairman of the Lung Committee with SWOG from 1998 to 2008. He sat on the Staging and Membership Committees of the International Association for the Study of Lung Cancer. His main interests are the combined modality approaches to thoracic malignancies, adjuvant therapy after lung cancer surgery, and clinical trials in thoracic oncology. He was the surgical PI of the S9900 Intergroup phase III trial which evaluated the role of pre-operative chemotherapy in lung cancer. Since 1997, he has led the combined modality efforts for the treatment of mesothelioma in Seattle and in the Pacific Northwest. Dr. Vallières has editorial responsibilities in the Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Journal of Thoracic Oncology, Clinical Lung Cancer, Chest, Lung Cancer, Annals of Surgical Oncology, Journal of Clinical Oncology and New England Journal of Medicine.